Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination
Tài liệu tham khảo
Keating, 2003, Recombinant hepatitis B vaccine, Drugs, 63, 1021, 10.2165/00003495-200363100-00006
Jilg, 1990, Decline of anti-HBs after hepatitis B vaccination and timing for revaccination, Lancet, 20, 173, 10.1016/0140-6736(90)90050-F
Lee, 1995, Long-term efficacy of recombinant hepatitis B vaccine and risk of infection in infants born to mothers with hepatitis B e antigen, Pediatrics, 126, 716, 10.1016/S0022-3476(95)70398-5
Wainwright, 1997, Protection provided by hepatitis B vaccine in a yupik Eskimo population: results of a 10-year study, J Infect Dis, 175, 674, 10.1093/infdis/175.3.674
Dentico, 2002, Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titers, Vaccine, 20, 3725, 10.1016/S0264-410X(02)00356-0
West, 1996, Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination, Vaccine, 14, 1019, 10.1016/0264-410X(96)00062-X
Banatvala, 2000, Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory, Vaccine, 19, 877, 10.1016/S0264-410X(00)00224-3
Lao, 1999, Long-term efficacy of plasmid-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children, Vaccine, 17, 2661, 10.1016/S0264-410X(99)00031-6
Li, 1998, Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization, World J Gastroenterol, 4, 493, 10.3748/wjg.v4.i6.493
European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000;355:561–5.
Wismans, 1991, A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls, J Med Virol, 35, 216, 10.1002/jmv.1890350313
Wismans, 1989, The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen, Clin Exp Immunol, 78, 75
Paroli, 2002, Long-lasting memory-resting and memory-effector CD4+ T cells in human X-linked agammaglobulinemia, Blood, 99, 2131, 10.1182/blood.V99.6.2131
Huang, 1999, Long-term response ID hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen, Hepatology, 29, 954, 10.1002/hep.510290349
Van Hattum, 1992, In vitro anti-HBs production by individual B cells of resonders to hepatitis B vaccination who lost anti-HBs, 774
Böcher, 1996, Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection, Clin Exp Immunol, 105, 52, 10.1046/j.1365-2249.1996.d01-732.x
Esser, 2003, Memory T cells and vaccines, Vaccine, 21, 419, 10.1016/S0264-410X(02)00407-3
Sprent, 2002, T cell memory, Annu Rev Immunol, 20, 551, 10.1146/annurev.immunol.20.100101.151926
Böcher, 1999, Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma, Hepatology, 29, 238, 10.1002/hep.510290120
Sylvan, 1990, HBsAg-induced interferon-gamma secretion in T cells from asymptomatic HBsAg carriers and HB-immune donors in vitro, Immunology, 70, 197
Tsutsui, 1991, There is no correlation between function and lymphokine production of HBs-antigen-specific human CD4(+)-cloned T cells, Scand J Immunol, 34, 433, 10.1111/j.1365-3083.1991.tb01566.x
Boxall EH, A Sira J, El-Shuhkri N, Kelly DA. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis 2004;190(7):1264–9.
Petersen, 2004, Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth, Pediatr Infect Dis J, 23, 650, 10.1097/01.inf.0000130952.96259.fd